Pfizer restarts production at tornado-hit North Carolina plant, but drug supply will still be affected
Publishing timestamp: 2023-09-25 16:40:05
Summary
Pfizer has restarted the majority of production lines at its drug manufacturing plant in North Carolina, which was heavily damaged by a tornado. The company expects operations to fully resume by the end of the year. However, some medicines from the facility may be in short supply until at least mid-2024. The plant supplies nearly 8% of all sterile injectable medicines used in U.S. hospitals. Pfizer has restarted production of 13 prioritized medicines based on patient need and inventory levels. The announcement comes at a time when the U.S. is already facing shortages of various medicines.
Sentiment: POSITIVE
Tickers: PFE,
Keywords: health care industry, pfizer inc, breaking news, business news, biotechnology, business, biotech and pharmaceuticals, pharmaceuticals,